Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis.
10.3350/cmh.2016.22.1.183
- Author:
Hye Young JWA
1
;
Yoo Kyung CHO
;
Eun Kwang CHOI
;
Heung Up KIM
;
Hyun Joo SONG
;
Soo Young NA
;
Sun Jin BOO
;
Seung Uk JEONG
;
Bong Soo KIM
;
Byoung Wook LEE
;
Byung Cheol SONG
Author Information
1. Department of Internal Medicine, Jeju National University School of Medicine, Jeju, Korea. drsong8177@naver.com
- Publication Type:Case Reports
- Keywords:
Hepatitis B virus;
Entecavir;
Esophageal varices;
Liver cirrhosis
- MeSH:
Abdomen/diagnostic imaging;
Antiviral Agents/*therapeutic use;
DNA, Viral/blood;
Esophageal and Gastric Varices/complications/prevention & control;
Guanine/*analogs & derivatives/therapeutic use;
Hepatitis B virus/genetics;
Hepatitis B, Chronic/complications/*drug therapy/virology;
Humans;
Liver Cirrhosis/*diagnosis/etiology;
Male;
Middle Aged;
Polymerase Chain Reaction;
Ultrasonography
- From:Clinical and Molecular Hepatology
2016;22(1):183-187
- CountryRepublic of Korea
- Language:English
-
Abstract:
Recent studies suggest that liver cirrhosis is reversible after administering oral nucleos(t)ide analogue therapy to patients with hepatitis B virus (HBV) infection. However, few studies have addressed whether esophageal varices can regress after such therapy. We report a case of complete regression of esophageal varices during entecavir therapy in patients with HBV-related liver cirrhosis, suggesting that complications of liver cirrhosis such as esophageal varices can regress after the long-term suppression of HBV replication.
